| 
																	
																		 
																		 Cross Reactions
 
																		 
																		
																	 
																		 
																		
																	 
																			
																					
	"Cross Reactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
 
	
	
		
			
			
				Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
    
			 
				
				
					
						| Descriptor ID | D003429 |  
						| MeSH Number(s) | G12.425.143.281 |  
						| Concept/Terms | Cross ReactionsCross ReactionsCross ReactionReaction, CrossReactions, Cross
 |  
				Below are MeSH descriptors whose meaning is more general than "Cross Reactions". 
				Below are MeSH descriptors whose meaning is more specific than "Cross Reactions". 
	
	
		
			
			
					
				This graph shows the total number of publications written about "Cross Reactions" by people in UAMS Profiles by year, and whether "Cross Reactions" was a major or minor topic of these publications.  
					  To see the data from this visualization as text, click here. 
		            | Year | Major Topic | Minor Topic | Total | 
|---|
 | 2024 | 1 | 0 | 1 |  | 2021 | 0 | 2 | 2 |  | 2020 | 0 | 2 | 2 |  | 2017 | 0 | 1 | 1 |  | 2016 | 0 | 1 | 1 |  | 2015 | 0 | 1 | 1 |  | 2013 | 0 | 1 | 1 |  | 2011 | 0 | 3 | 3 |  | 2009 | 0 | 1 | 1 |  | 2008 | 0 | 1 | 1 |  | 2007 | 0 | 1 | 1 |  | 2006 | 1 | 1 | 2 |  | 2005 | 0 | 2 | 2 |  | 2003 | 0 | 3 | 3 |  | 2002 | 0 | 1 | 1 |  | 2001 | 0 | 2 | 2 |  | 2000 | 0 | 2 | 2 |  | 1999 | 0 | 1 | 1 |  | 1997 | 0 | 1 | 1 |  | 1992 | 0 | 1 | 1 | 
 
                    To return to the timeline, click here. 
				Below are the most recent publications written about "Cross Reactions" by people in Profiles over the past ten years. 		
					
								
								Kelley JT, Kroll-Wheeler L, Hrycaj S, Chan MP, Cheng J, Lamps LW. Nonspecificity of Immunohistochemistry for Mycobacteria Species Using a Rabbit Polyclonal Antibody. Arch Pathol Lab Med. 2024 Nov 01; 148(11):e367-e373.
								Kieber-Emmons T. Broad Based Immunity? Monoclon Antib Immunodiagn Immunother. 2022 10; 41(5):229-230.
								Jette CA, Cohen AA, Gnanapragasam PNP, Muecksch F, Lee YE, Huey-Tubman KE, Schmidt F, Hatziioannou T, Bieniasz PD, Nussenzweig MC, West AP, Keeffe JR, Bjorkman PJ, Barnes CO. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies. Cell Rep. 2021 09 28; 36(13):109760.
								Cohen AA, Gnanapragasam PNP, Lee YE, Hoffman PR, Ou S, Kakutani LM, Keeffe JR, Wu HJ, Howarth M, West AP, Barnes CO, Nussenzweig MC, Bjorkman PJ. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science. 2021 02 12; 371(6530):735-741.
								Saad-Roy CM, Wagner CE, Baker RE, Morris SE, Farrar J, Graham AL, Levin SA, Mina MJ, Metcalf CJE, Grenfell BT. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years. Science. 2020 11 13; 370(6518):811-818.
								Barnes CO, West AP, Huey-Tubman KE, Hoffmann MAG, Sharaf NG, Hoffman PR, Koranda N, Gristick HB, Gaebler C, Muecksch F, Lorenzi JCC, Finkin S, H?ggl?f T, Hurley A, Millard KG, Weisblum Y, Schmidt F, Hatziioannou T, Bieniasz PD, Caskey M, Robbiani DF, Nussenzweig MC, Bjorkman PJ. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. Cell. 2020 08 20; 182(4):828-842.e16.
								Poston TB, Qu Y, Girardi J, O'Connell CM, Frazer LC, Russell AN, Wall M, Nagarajan UM, Darville T. A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function. J Immunol. 2017 10 15; 199(8):2845-2854.
								Yao X, Lu YC, Parker LL, Li YF, El-Gamil M, Black MA, Xu H, Feldman SA, van der Bruggen P, Rosenberg SA, Robbins PF. Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy. J Immunother. 2016 06; 39(5):191-201. | 
																	
																		
																			
																					People  People who have written about this concept._ 
    
        Similar Concepts   
        People who have written about this concept.
     _ 
    
        Top Journals   
        Top journals in which articles about this concept have been published.
     |